Enclavia.ai is developing an end-to-end, compliance-native AI platform to help MedTech CMOs and CEOs reduce clinical trial timelines and costs across the full lifecycle — from protocol design to post-market evidence and reimbursement — using a zero-migration architecture that connects to the sponsor’s existing data, runs on the sponsor’s choice of 12 LLMs, and ships SOC 2 + HIPAA + 21 CFR Part 11 + EU MDR compliance natively
Shared 8 months ago
13 views